MedWatch

Leading Danish scientist in search of groundbreaking stem cell-answers in new EU-project

Within the next five years one of Denmark’s leading cancer researchers is hoping to gain a clear understanding of why stem cells sometimes develop cancer tumors when used for medical treatment – the way to do that is through a broad EU-collaboration.

Foto: Martin Mydtskov

In collaboration with a number of research units and companies, the Danish cancer biologist Kristian Helin now has to use his many years of experience to crack the code and discover the intricate and crucial answers concerning embryonic stem cells.

The new EU-project, 4DCellFate, focuses on an understanding of why the growth of stem cells is regulated. Eight academic institutions, three biotech companies and one pharmaceutical company join hands to share knowledge and create results backed by 12 million Euros in EU-funds.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Genmab-partner trækker sig fra samarbejde

Abbvie ønsker ikke længere at udvikle en fælles kræftkandidat med Genmab, men biotekselskabet skal stadig betale royalites af et eventuelt fremtidigt salg ved kommercialisering.

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier